Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application

ClinicalTrials.gov ID: NCT05094089

Public ClinicalTrials.gov record NCT05094089. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort, international, post-market clinical investigation looking into the assessment of GORE® SYNECOR Biomaterial in focused patient populations and in long-term application. Patients with ventral / incisional hernia amenable to hernia mesh repair will be enrolled into two cohorts (US and EU cohort) and followed-up over the period of 60 months.

Study identification

NCT ID
NCT05094089
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
W.L.Gore & Associates
Industry
Enrollment
320 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 24, 2023 (Actual)
Primary completion
Jul 31, 2030 (Estimated)
Completion
Jul 31, 2030 (Estimated)
Last update posted
Jan 21, 2026

2023 – 2030

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
Emory Saint Joseph's Hospital Atlanta Georgia 30342 —
Tufts Medical Center Boston Massachusetts 02111 —
Corewell Health Grand Rapids Michigan 49506 —
Lovelace Women's Hospital Albuquerque New Mexico 87109 —
Stony Brook University Hospital Stony Brook New York 11794 —
Novant Health New Hanover Regional Medical Center Wilmington North Carolina 28401 —
Prisma Health Greenville Memorial Hospital Greenville South Carolina 29605 —
Bon Secours Memorial Regional Medical Center Mechanicsville Virginia 23116 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05094089, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 21, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05094089 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →